NeoGenomics reviews

3.2

55% would recommend to a friend

(130 total reviews)

Tony Zook

50% approve of CEO

43% positive business outlook

Reviews by job title

130 reviews

Reviews about "Culture"

Return to all reviews
5.0
Mar 6, 2026
Recommend
CEO approval
Business Outlook

Pros

Working at NeoGenomics has been an incredibly rewarding experience. The company truly stands out for its commitment to advancing cancer diagnostics and improving patient outcomes. Knowing that the work we do directly contributes to helping physicians make better treatment decisions gives a real sense of purpose every day. One of the things that makes NeoGenomics such a great place to work is the culture. The environment is collaborative, supportive, and filled with talented professionals who are passionate about what they do. Team members are always willing to help one another, share knowledge, and work together to solve complex challenges. Leadership also does a great job of encouraging professional growth. There are opportunities to learn new skills, take on new responsibilities, and grow within the company. Employees are recognized for their contributions, and management genuinely values feedback and ideas from the team. Another highlight is the strong focus on quality and innovation. NeoGenomics is constantly investing in new technologies and improving processes to stay at the forefront of cancer testing and precision medicine. Being part of an organization that is pushing the boundaries of science and making a real difference in patients’ lives is something I’m proud of. Overall, NeoGenomics offers a meaningful mission, supportive colleagues, and opportunities for growth. It’s a place where employees can feel valued while contributing to work that truly matters.

Cons

None that I can think of right now.

2.0
Mar 5, 2026
Recommend
CEO approval
Business Outlook

Pros

Steady amount of chaos to keep you busy. No shortage of cancer testing incoming. Financials improving on paper.

Cons

The new CEO, and CIO came from the board of directors. New management came from smaller company mergers. New leadership, new direction. Neo is still a big company made up of a bunch of smaller company bolt-ons that haven't fully integrated. Cancelled contracts, budget cuts, mass staff-layoffs. The morale is low in IT. They rebranded IT as "Digital Technology Solutions"

2.0
Mar 2, 2026
Recommend
CEO approval
Business Outlook

Pros

The workforce wants to do the right thing. We take pride in knowing our services impact people's lives everyday.

Cons

Constant turnover, lack of communication throughout - top to bottom. Leadership is struggling and not performing, Most of their attempts to improve growth have lost money. This is factual, not to be mistaken with statements from a disgruntled employee. An article published after the recent earnings release emphasized NEO's 5-year Return on Invested Capital is -10.5%, meaning management doesn't spend our capital wisely. This, along with heavy debt, minimal cash and returns at the bottom of the healthcare sector, should make you pause and do more research before jumping on board.

Viewing 4 - 6 of 130 Reviews

Glassdoor has 515 NeoGenomics reviews submitted anonymously by NeoGenomics employees. Read employee reviews and ratings on Glassdoor to decide if NeoGenomics is right for you.